# Use of Arimidex and Zoladex as Pretreatment to IVF in Women With Ovarian Endometriosis

> **NCT00286351** · PHASE4 · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 20 (—)

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** Combined treatment with Arimidex and Zoladex before IVF

## Key facts

- **NCT ID:** NCT00286351
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 20 (—)
- **Last updated:** 2007-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00286351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00286351, "Use of Arimidex and Zoladex as Pretreatment to IVF in Women With Ovarian Endometriosis". Retrieved via MORVS 2026-10-16 from https://api.morvs.ai/clinical/NCT00286351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*